Arcutis Biotherapeutics, Inc. (ARQT) vs Viking Therapeutics, Inc. (VKTX)
- Arcutis Biotherapeutics, Inc. ARQT 25.55 −5.37%
- Viking Therapeutics, Inc. VKTX 26.82 +3.99%
Arcutis Biotherapeutics, Inc. and Viking Therapeutics, Inc. are both Biotechnology companies. Arcutis Biotherapeutics, Inc. and Viking Therapeutics, Inc. are of similar size ($3.4B and $3.3B). Viking Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Arcutis Biotherapeutics, Inc. trades at 112×. Arcutis Biotherapeutics, Inc. has the higher net margin (5.88% vs 0.00%) and the higher return on invested capital (23.5% vs 0.00%). Across the 14 metrics below, Arcutis Biotherapeutics, Inc. leads on 10 and Viking Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ARQT | VKTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.18% | 0.00% | 68.51% |
| Operating margin | 6.91% | 0.00% | 0.00% |
| Net margin | 5.88% | 0.00% | 0.00% |
| Free cash flow margin | 11.74% | 0.00% | 0.00% |
| Return on equity | 14.88% | (96.37%) | (51.96%) |
| Return on assets | 6.68% | (73.07%) | (46.06%) |
| Return on invested capital | 23.48% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack